Sugar coating reveals black death

July 17, 2013, Angewandte Chemie

Even today, the lives of humans and animals are claimed by plague. A new antibody-based detection method can be used to reliably and sensitively identify plague in patient serum and other biological samples. The antibody specifically recognizes a particular carbohydrate structure found on the cell surfaces of the bacterium that causes plague, as reported by German researchers in the journal Angewandte Chemie.

"Black death" took the lives of over 200 million humans over the course of three in the last 1500 years. More recently, cases of plague have been detected in Africa and Asia. Because of the high danger of transmission and the severity of the infection, Yersinia pestis, the pathogen behind the plague, is classified as a category A . When inhaled as an aerosol it causes pneumonic plague, which usually results in death if it is not treated fast. Rapid and reliable diagnosis is thus critical.

"Currently, Y. pestis is detected by based assays or traditional phenotyping," explains Peter Seeberger of the Max Planck Institute of Colloids and Interfaces in Potsdam. "These methods of detection are reliable, but they are also often complex, expensive, and slow." The recognition of by antibodies is a highly promising and less complicated alternative method for the detection of plague, but it has a high failure rate and low selectivity with regard to related strains of bacteria.

Seeberger and his team have now found a way around this problem: Gram-negative bacteria like Y. pestis have molecules called lipopolysaccharides (LPSs), made of fat and carbohydrate components, on their outer cell membranes. "The inner core of the Yersinia LPS has a unique structure that differs from that of other Gram-negative bacteria," says Seeberger. "This could be a suitable region for detection by means of specific antibodies for rapid point-of-care diagnosis."

Because isolation of Y. pestis LPS is a laborious undertaking, the researchers chose to synthetically produce one typical motif from the molecule, a segment consisting of three sugar molecules, each of which has a framework of seven carbon atoms. The researchers attached these segments, called triheptoses, to diphtherietoxoid CRM197, which acts as a carrier protein. This protein is a typical component of licensed vaccine formulations and triggers the formation of antibodies. The researchers immunized mice and isolated antibodies from their blood.

Various immunoassays demonstrated that the resulting antibodies detect the plague pathogen with high selectivity and sensitivity, and selectively differentiate between Y. pestis and other Gram-negative bacteria. The researchers hope to be able to use this to develop applications for patient diagnostics. The development of corresponding tests is the focus of their current research.

Explore further: New discovery in battle against plague and bacterial pneumonias

More information: Angewandte Chemie International Edition, DOI 10.1002/anie.201301633

Related Stories

New discovery in battle against plague and bacterial pneumonias

June 27, 2011
Researchers from the Smiley lab at the Trudeau Institute have now identified a single component of the plague causing bacterium that can be used as a vaccine. This single "subunit" could potentially be used to create a safer ...

US approves new treatment for ancient plague

April 27, 2012
Hardly anyone succumbs to the bubonic plague these days, but US health authorities on Friday approved a new treatment for it and other forms of the potentially deadly bacterial infection.

Scientists confirm Justinianic Plague caused by bacterium Yersinia pestis

May 10, 2013
(Medical Xpress)—From the several pandemics generally called 'pestilences' three are historically recognized as due to plague, but only for the third pandemic of the 19th-21st centuries AD there were microbiological evidences ...

Recommended for you

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.